North America Genome Sequencing Market 2022-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity
- Report ID: 29713
- Date: Jun, 2022
- Pages: 103
- Category: Healthcare & Pharmaceuticals
North America genome sequencing market is projected to grow by 11.5% annually in the forecast period and reach $10.77 billion by 2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine.
Highlighted with 23 tables and 49 figures, this 103-page report “North America Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America genome sequencing market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America genome sequencing market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Consumables
• Sequencers & Software
• Service
Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymerase Chain Reaction (PCR)
• Sequencing
• Microarray
• Nucleic Acid Extraction and Purification
• Other Technologies
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Diagnostics
o Oncology
o Reproductive Health
o Complex Disease Research
o Other Diagnostics
• Drug Discovery and Development
• Precision Medicine
• Agriculture and Animal Research
• Other Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Academic & Research Centers
• Pharmaceutical and Biotechnology Companies
• Consumer Genomic Service Providers
• Government Institutes
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
BGI
Biomatters
Bio-Rad Laboratories, Inc.
DNASTAR
F. Hoffmann-La Roche
Illumina, Inc.
Macrogen Inc.
Myriad Genetics, Inc.
New England Biolabs
Oxford Nanopore Technology
PerkinElmer Inc.
Qiagen
Siemens Healthineers
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of North America Market by Product 43
3.1 Market Overview by Product 43
3.2 Consumables 45
3.3 Sequencers & Software 46
3.4 Service 47
4 Segmentation of North America Market by Technology 48
4.1 Market Overview by Technology 48
4.2 Polymerase Chain Reaction (PCR) 50
4.3 Sequencing 51
4.4 Microarray 52
4.5 Nucleic Acid Extraction and Purification 53
4.6 Other Technologies 54
5 Segmentation of North America Market by Application 55
5.1 Market Overview by Application 55
5.2 Diagnostics 57
5.2.1 Oncology 59
5.2.2 Reproductive Health 60
5.2.3 Complex Disease Research 61
5.2.4 Other Diagnostics 62
5.3 Drug Discovery and Development 63
5.4 Precision Medicine 64
5.5 Agriculture and Animal Research 65
5.6 Other Applications 66
6 Segmentation of North America Market by End User 67
6.1 Market Overview by End User 67
6.2 Academic & Research Centers 69
6.3 Pharmaceutical and Biotechnology Companies 70
6.4 Consumer Genomic Service Providers 71
6.5 Government Institutes 72
6.6 Other End Users 73
7 North America Market 2019-2030 by Country 74
7.1 Overview of North America Market 74
7.2 U.S. 77
7.3 Canada 80
7.4 Mexico 82
8 Competitive Landscape 84
8.1 Overview of Key Vendors 84
8.2 New Product Launch, Partnership, Investment, and M&A 87
8.3 Company Profiles 88
BGI 88
Biomatters 90
Bio-Rad Laboratories, Inc. 91
DNASTAR 92
F. Hoffmann-La Roche 93
Illumina, Inc. 94
Macrogen Inc. 95
Myriad Genetics, Inc. 96
New England Biolabs 97
Oxford Nanopore Technology 98
PerkinElmer Inc. 99
Qiagen 100
Siemens Healthineers 101
Thermo Fisher Scientific 102
RELATED REPORTS 103
List of Tables
Table 1. Snapshot of North America Genome Sequencing Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 31
Table 4. Main Product Trends and Market Opportunities in North America Genome Sequencing Market 35
Table 5. North America Genome Sequencing Market by Product, 2019-2030, $ mn 43
Table 6. North America Genome Sequencing Market by Technology, 2019-2030, $ mn 48
Table 7. North America Genome Sequencing Market by Application, 2019-2030, $ mn 55
Table 8. North America Genome Sequencing Market: Diagnostics by Type, 2019-2030, $ mn 58
Table 9. North America Genome Sequencing Market by End User, 2019-2030, $ mn 67
Table 10. North America Genome Sequencing Market by Country, 2019-2030, $ mn 75
Table 11. U.S. Genome Sequencing Market by Product, 2019-2030, $ mn 79
Table 12. U.S. Genome Sequencing Market by Application, 2019-2030, $ mn 79
Table 13. U.S. Genome Sequencing Market by End User, 2019-2030, $ mn 79
Table 14. Canada Genome Sequencing Market by Product, 2019-2030, $ mn 81
Table 15. Canada Genome Sequencing Market by Application, 2019-2030, $ mn 81
Table 16. Canada Genome Sequencing Market by End User, 2019-2030, $ mn 81
Table 17. Mexico Genome Sequencing Market by Product, 2019-2030, $ mn 83
Table 18. Mexico Genome Sequencing Market by Application, 2019-2030, $ mn 83
Table 19. Mexico Genome Sequencing Market by End User, 2019-2030, $ mn 83
Table 20. BGI: Company Snapshot 88
Table 21. BGI: Business Segmentation 88
Table 22. BGI: Product Portfolio 89
Table 23. BGI: Revenue, 2018-2020, $ mn 89
List of Figures
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Genome Sequencing Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Genome Sequencing Market 25
Figure 7. World Number of Deaths by Cause in 2017 28
Figure 8. World Number of Deaths from Cancers in 2017 29
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 11. Primary Restraints and Impact Factors of North America Genome Sequencing Market 32
Figure 12. Investment Opportunity Analysis 36
Figure 13. Porter’s Fiver Forces Analysis of North America Genome Sequencing Market 39
Figure 14. Breakdown of North America Genome Sequencing Market by Product, 2019-2030, % of Revenue 44
Figure 15. North America Addressable Market Cap in 2021-2030 by Product, Value ($ mn) and Share (%) 44
Figure 16. North America Genome Sequencing Market by Product: Consumables, 2019-2030, $ mn 45
Figure 17. North America Genome Sequencing Market by Product: Sequencers & Software, 2019-2030, $ mn 46
Figure 18. North America Genome Sequencing Market by Product: Service, 2019-2030, $ mn 47
Figure 19. Breakdown of North America Genome Sequencing Market by Technology, 2019-2030, % of Sales Revenue 49
Figure 20. North America Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%) 49
Figure 21. North America Genome Sequencing Market by Technology: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 50
Figure 22. North America Genome Sequencing Market by Technology: Sequencing, 2019-2030, $ mn 51
Figure 23. North America Genome Sequencing Market by Technology: Microarray, 2019-2030, $ mn 52
Figure 24. North America Genome Sequencing Market by Technology: Nucleic Acid Extraction and Purification, 2019-2030, $ mn 53
Figure 25. North America Genome Sequencing Market by Technology: Other Technologies, 2019-2030, $ mn 54
Figure 26. Breakdown of North America Genome Sequencing Market by Application, 2019-2030, % of Sales Revenue 56
Figure 27. North America Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%) 56
Figure 28. North America Genome Sequencing Market by Application: Diagnostics, 2019-2030, $ mn 57
Figure 29. North America Genome Sequencing Market by Diagnostics: Oncology, 2019-2030, $ mn 59
Figure 30. North America Genome Sequencing Market by Diagnostics: Reproductive Health, 2019-2030, $ mn 60
Figure 31. North America Genome Sequencing Market by Diagnostics: Complex Disease Research, 2019-2030, $ mn 61
Figure 32. North America Genome Sequencing Market by Diagnostics: Other Diagnostics, 2019-2030, $ mn 62
Figure 33. North America Genome Sequencing Market by Application: Drug Discovery and Development, 2019-2030, $ mn 63
Figure 34. North America Genome Sequencing Market by Application: Precision Medicine, 2019-2030, $ mn 64
Figure 35. North America Genome Sequencing Market by Application: Agriculture and Animal Research, 2019-2030, $ mn 65
Figure 36. North America Genome Sequencing Market by Application: Other Applications, 2019-2030, $ mn 66
Figure 37. Breakdown of North America Genome Sequencing Market by End User, 2019-2030, % of Revenue 68
Figure 38. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 68
Figure 39. North America Genome Sequencing Market by End User: Academic & Research Centers, 2019-2030, $ mn 69
Figure 40. North America Genome Sequencing Market by End User: Pharmaceutical and Biotechnology Companies, 2019-2030, $ mn 70
Figure 41. North America Genome Sequencing Market by End User: Consumer Genomic Service Providers, 2019-2030, $ mn 71
Figure 42. North America Genome Sequencing Market by End User: Government Institutes, 2019-2030, $ mn 72
Figure 43. North America Genome Sequencing Market by End User: Other End Users, 2019-2030, $ mn 73
Figure 44. Breakdown of North America Genome Sequencing Market by Country, 2019 and 2030, % of Revenue 75
Figure 45. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 76
Figure 46. U.S. Genome Sequencing Market, 2019-2030, $ mn 78
Figure 47. Canada Genome Sequencing Market, 2019-2030, $ mn 80
Figure 48. Genome Sequencing Market in Mexico, 2019-2030, $ mn 82
Figure 49. Growth Stage of North America Genome Sequencing Industry over the Forecast Period 84
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
